Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English
En español
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director
Dictionary of Cancer Terms
Cancer-related terms
NCI Drug Dictionary
Definitions, names, and links
Funding Opportunities
Research and training
NCI Publications
Order/download free booklets
Advisory Boards and Groups
Information, meetings, reports
Science Serving People
Learn more about NCI
Español
Información en español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
NCI Responds to Hurricanes
The Nation's Investment in Cancer Research FY 2009
Cancer Trends Progress Report: 2007 Update
Past Highlights
You CAN Quit Smoking Now!
Search for
keyword
Starts with
Contains
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
In English
En español
polyglutamate camptothecin
(PAH-lee-GLOO-tuh-mayt kamp-toh-THEK-in)
A form of the anticancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called CT-2106.
Previous Definitions:
polifeprosan 20 carmustine implant
,
poly-ICLC
,
polycystic ovary syndrome
,
polycythemia vera
,
polyethylene glycosylated recombinant human megakaryocyte growth and development factor
Next Definitions:
polymer
,
polymerase chain reaction
,
polymorphism
,
polymyositis
,
polyneuritis
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute